These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6235119)

  • 1. Effects of selective dopamine D2-receptor agonists on the release of cholecystokinin-like immunoreactivity from rat neostriatum.
    Conzelmann U; Holland A; Meyer DK
    Eur J Pharmacol; 1984 May; 101(1-2):119-25. PubMed ID: 6235119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of cholecystokinin release from posterior nucleus accumbens by D-2 dopamine receptor.
    Martin JR; Beinfeld MC; Wang RY
    Brain Res; 1986 Nov; 397(2):253-8. PubMed ID: 2948613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of gamma-aminobutyric acid-receptors of the B-subtype inhibits the dopamine-induced enhancement of the release of cholecystokinin-like immunoreactivity from slices of rat dorsal caudatoputamen.
    Conzelmann U; Meyer DK
    Naunyn Schmiedebergs Arch Pharmacol; 1987 May; 335(5):541-6. PubMed ID: 3039381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposing effects of dopamine D2 receptor stimulation on the spontaneous and the electrically evoked release of [3H]GABA on rat prefrontal cortex slices.
    Rétaux S; Besson MJ; Penit-Soria J
    Neuroscience; 1991; 42(1):61-71. PubMed ID: 1677746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release of cholecystokinin from rat midbrain slices and modulatory effect of D2DA receptor stimulation.
    Freeman AS; Chiodo LA; Lentz SI; Wade K; Bannon MJ
    Brain Res; 1991 Aug; 555(2):281-7. PubMed ID: 1682000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. False labelling of dopaminergic terminals in the rabbit caudate nucleus: uptake and release of [3H]-5-hydroxytryptamine.
    Feuerstein TJ; Hertting G; Lupp A; Neufang B
    Br J Pharmacol; 1986 Jul; 88(3):677-84. PubMed ID: 3742155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of D2-dopamine receptors in rat neostriatum inhibits the release of acetylcholine and dopamine but does not affect the release of gamma-aminobutyric acid, glutamate or serotonin.
    Stoof JC; De Boer T; Sminia P; Mulder AH
    Eur J Pharmacol; 1982 Oct; 84(3-4):211-4. PubMed ID: 6129151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine modulates cholecystokinin release in neostriatum.
    Meyer DK; Krauss J
    Nature; 1983 Jan; 301(5898):338-40. PubMed ID: 6823307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S; Lucki I; McGonigle P
    Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential visualization of dopamine D2 and D3 receptors in rat brain.
    Parsons B; Stanley M; Javitch J
    Eur J Pharmacol; 1993 Apr; 234(2-3):269-72. PubMed ID: 8097723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D2 receptor stimulation inhibits inositol phosphate generating system in rat striatal slices.
    Pizzi M; Da Prada M; Valerio A; Memo M; Spano PF; Haefely WE
    Brain Res; 1988 Jul; 456(2):235-40. PubMed ID: 2974746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotensin-induced dopamine release in vivo and in vitro from substantia nigra and nucleus caudate.
    Faggin BM; Zubieta JK; Rezvani AH; Cubeddu LX
    J Pharmacol Exp Ther; 1990 Feb; 252(2):817-25. PubMed ID: 2138224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACTH-(1-24) enhances the electrically stimulated release of [3H]dopamine from rat septal slices via a dopamine D2 receptor-independent mechanism.
    Florijn WJ; Versteeg DH
    Brain Res; 1989 Aug; 494(2):247-54. PubMed ID: 2550107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent in vitro regulation by the D-2 dopamine receptor of dopamine-stimulated efflux of cyclic AMP and K+-stimulated release of acetylcholine from rat neostriatum.
    Stoof JC; Kebabian JW
    Brain Res; 1982 Nov; 250(2):263-70. PubMed ID: 6293642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D2-dopamine receptor-mediated inhibition of intracellular Ca2+ mobilization and release of acetylcholine from guinea-pig neostriatal slices.
    Fujiwara H; Kato N; Shuntoh H; Tanaka C
    Br J Pharmacol; 1987 Jun; 91(2):287-97. PubMed ID: 2886167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of endogenous dopamine and cholecystokinin from rat striatal slices: effects of amphetamine and dopamine antagonists.
    Hutchison JB; Strupish J; Nahorski SR
    Brain Res; 1986 Apr; 370(2):310-4. PubMed ID: 3708329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta.
    Lacey MG; Mercuri NB; North RA
    J Physiol; 1987 Nov; 392():397-416. PubMed ID: 2451725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The regulation of cholecystokinin release from rat caudatoputamen in vitro.
    Gysling K; Beinfeld MC
    Brain Res; 1987 Mar; 407(1):110-6. PubMed ID: 2884011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D2- but not D1-dopamine receptors are involved in the inhibitory control of alpha-melanocyte-stimulating hormone release from the rat hypothalamus.
    Tiligada E; Wilson JF
    Exp Brain Res; 1989; 74(3):645-8. PubMed ID: 2540019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of D2 autoreceptor-mediated modulation of K(+)-evoked dopamine release in the neostriatum.
    Andersen SL; Gazzara RA
    Brain Res Dev Brain Res; 1994 Mar; 78(1):123-30. PubMed ID: 7911744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.